Despite a crowded GLP-1 drug development field, Structure's oral small molecule approach and strong financial position offer ...

Medifast, Inc. faces declining demand amid GLP-1 impact, struggling repositioning efforts, and earnings uncertainty. Read ...

Use of cutting-edge weight-loss drugs like Ozempic and Zepbound has increased dramatically among people with type 1 diabetes, raising safety concerns among experts, a new study says.

Liraglutide is a peptide that has gained significant attention in scientific research due to its structural similarity to ...

Spending growth for simple medications used to treat common health problems is outstripping spending growth for pricey medications used to treat complex and chronic conditions, according to a new ...

Collective Health, a leader in employee health benefits, and digital healthcare leader Noom’s enterprise division, Noom Health, have partnered to deliver Collective Health + Noom Med with SmartRx, an ...

On average, clients covering GLP-1 drugs for weight loss would have seen ... “We know that without a better cost management structure, most employers are unable to cover these life-changing ...